Spectral Medical Inc
TSX:EDT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.32
0.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one EDT stock under the Base Case scenario is 0.04 CAD. Compared to the current market price of 0.57 CAD, Spectral Medical Inc is Overvalued by 93%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Spectral Medical Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for EDT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Spectral Medical Inc
Balance Sheet Decomposition
Spectral Medical Inc
Current Assets | 9.1m |
Cash & Short-Term Investments | 7.5m |
Receivables | 352k |
Other Current Assets | 1.2m |
Non-Current Assets | 983k |
PP&E | 799k |
Intangibles | 184k |
Current Liabilities | 15m |
Accounts Payable | 2.8m |
Other Current Liabilities | 12.3m |
Non-Current Liabilities | 17.9m |
Long-Term Debt | 12.6m |
Other Non-Current Liabilities | 5.3m |
Earnings Waterfall
Spectral Medical Inc
Revenue
|
1.9m
CAD
|
Cost of Revenue
|
-1.2m
CAD
|
Gross Profit
|
713k
CAD
|
Operating Expenses
|
-14.4m
CAD
|
Operating Income
|
-13.7m
CAD
|
Other Expenses
|
-4.8m
CAD
|
Net Income
|
-18.5m
CAD
|
Free Cash Flow Analysis
Spectral Medical Inc
CAD | |
Free Cash Flow | CAD |
EDT Profitability Score
Profitability Due Diligence
Spectral Medical Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Spectral Medical Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
EDT Solvency Score
Solvency Due Diligence
Spectral Medical Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Score
Spectral Medical Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
EDT Price Targets Summary
Spectral Medical Inc
According to Wall Street analysts, the average 1-year price target for EDT is 2.04 CAD with a low forecast of 2.02 CAD and a high forecast of 2.1 CAD.
Dividends
Current shareholder yield for EDT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 31 full-time employees. The firm has conducted a Phase III clinical trial for its lead product, PMX (Toraymyxin PMX-20R), which is for the treatment of patients with septic shock and endotoxemia that is measured by the Company’s Endotoxin Activity Assay (EAA). EAA and PMX are both Health Canada licensed and commercially available in Canada. The firm through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new set of platforms addressing renal replacement therapy (RRT) across the dialysis spectrum. SAMI is targeting the acute RRT market, while DIMI is targeting the chronic RRT market.
Contact
IPO
Employees
Officers
The intrinsic value of one EDT stock under the Base Case scenario is 0.04 CAD.
Compared to the current market price of 0.57 CAD, Spectral Medical Inc is Overvalued by 93%.